Literature DB >> 11157492

Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals.

M Eguchi-Ishimae1, M Eguchi, E Ishii, S Miyazaki, K Ueda, N Kamada, S Mizutani.   

Abstract

TEL-AML1 fusion resulting from the t(12;21)(p13;q22) is one of the most common genetic abnormalities in childhood acute lymphoblastic leukemia. Recent findings that site-specific cleavage of the MLL gene can be induced by chemotherapeutic agents such as topoisomerase-II inhibitors suggest that apoptogenic agents can cause chromosomal translocations in hematopoietic cells. This study demonstrates a possible relationship between exposure to apoptogenic stimuli, TEL breaks, and the formation of TEL-AML1 fusion in immature B lymphocytes. Short-term culture of immature B cell lines in the presence of apoptogenic stimuli such as serum starvation, etoposide, or salicylic acid induced double-strand breaks (DSBs) in intron 5 of the TEL gene and intron 1 of the AML1 gene. TEL-AML1 fusion transcripts were also identified by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis in cell lines treated by serum starvation or aminophylline. DSBs within the TEL gene were also associated with fusion to other unknown genes, presumably as a result of chromosomal translocation. We also examined 67 cord blood and 147 normal peripheral blood samples for the existence of in-frame TEL-AML1 fusion transcripts. One cord blood sample (1.5%) and 13 normal peripheral blood samples (8.8%) were positive as detected by nested RT-PCR. These data suggest that breakage and fusion of TEL and AML1 may be relatively common events and that sublethal apoptotic signals could play a role in initiating leukemogenesis via the promotion of DNA damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157492     DOI: 10.1182/blood.v97.3.737

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

Review 1.  Somatic mosaicism: on the road to cancer.

Authors:  Luis C Fernández; Miguel Torres; Francisco X Real
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

2.  Calcium salicylate-mediated apoptosis in human HT-1080 fibrosarcoma cells.

Authors:  J G Mahdi; M A Alkarrawi; A J Mahdi; I D Bowen; D Humam
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

Review 3.  Causes of oncogenic chromosomal translocation.

Authors:  Peter D Aplan
Journal:  Trends Genet       Date:  2005-10-28       Impact factor: 11.639

Review 4.  Intergenically Spliced Chimeric RNAs in Cancer.

Authors:  Yuemeng Jia; Zhongqiu Xie; Hui Li
Journal:  Trends Cancer       Date:  2016-09

5.  Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancer.

Authors:  Eric Kowarz; Jennifer Merkens; Michael Karas; Theo Dingermann; Rolf Marschalek
Journal:  Am J Blood Res       Date:  2011-04-07

6.  Five percent of healthy newborns have an ETV6-RUNX1 fusion as revealed by DNA-based GIPFEL screening.

Authors:  Daniel Schäfer; Marianne Olsen; David Lähnemann; Martin Stanulla; Robert Slany; Kjeld Schmiegelow; Arndt Borkhardt; Ute Fischer
Journal:  Blood       Date:  2018-01-08       Impact factor: 22.113

7.  Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.

Authors:  Yanming Zhang; Pamela Strissel; Reiner Strick; Jianjun Chen; Giuseppina Nucifora; Michelle M Le Beau; Richard A Larson; Janet D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

Review 8.  Cytogenetic instability in childhood acute lymphoblastic leukemia survivors.

Authors:  María Sol Brassesco; Danilo Jordão Xavier; Marjori Leiva Camparoto; Ana Paula Montaldi; Paulo Roberto D'Auria Vieira de Godoy; Carlos Alberto Scrideli; Luiz Gonzaga Tone; Elza Tiemi Sakamoto-Hojo
Journal:  J Biomed Biotechnol       Date:  2010-08-31

9.  In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells.

Authors:  Eiichi Ishii; Mariko Eguchi; Minenori Eguchi-Ishimae; Nobuyuki Yoshida; Megumi Oda; Masafumi Zaitsu; Ichiro Fujita; Sumio Miyazaki; Yuhei Hamasaki; Shuki Mizutani
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

Review 10.  The prenatal origins of cancer.

Authors:  Glenn M Marshall; Daniel R Carter; Belamy B Cheung; Tao Liu; Marion K Mateos; Justin G Meyerowitz; William A Weiss
Journal:  Nat Rev Cancer       Date:  2014-03-06       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.